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Aim: To study the inﬂuence of segment width on plan quality for volumetric modulated arc
based stereotactic body radiotherapy.
Background: The redundancy of modulation for regularly shaped small volume tumors results
in  creation of many small segments and an increase of monitor units, with a consequent
prolongation of treatment and uncertainty in treatment delivery.
Materials and methods: Six cases each in lung, abdomen and liver were taken for the study.
For  each case, three VMAT SBRT plans were generated with different penalties on minimum
segment width of 0.5, 1.0 and 1.5 cm. A comparison was made on the metrics of dose volume
histogram, dosimetric indices, monitor units (MUs) and delivery accuracy.
Results: The mean reduction of total MUs when compared with 0.5 cm plan was observed as
12.7 ± 6.0% and 17.5 ± 7.2% for 1.0 cm and 1.5 cm of minimum segment width, respectively.
The  p value showed a signiﬁcant degradation in dosimetric indices for 1.5 cm plans when
compared with 0.5 cm and 1.0 cm plans. The average deviation of measured dose with TPS
calculated was 3.0 ± 1.1%, 2.1 ± 0.84% and 1.8 ± 0.9% for 0.5, 1.0 and 1.5 cm, respectively.
The  calculated gamma index with pass criteria of 2% dose difference and 2 mm distance to
agreement was 95.9 ± 2.8%, 96.5 ± 2.6% and 97.8 ± 1.6% as calculated for 0.5, 1.0 and 1.5 cm of
penalties, respectively. In view of the trade off between delivery efﬁciency and plan quality,
1  cm minimum segment width plans showed an improvement.Conclusions: VMAT SBRT plans with increased optimal value of minimum segment width
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1.  Background
Intensity modulated arc therapy is a widely accepted mode
of delivery for all regimens of radiotherapy. This novel radia-
tion technique, named as Volumetric Modulated Arc Therapy
(VMAT), allows a simultaneous variation of three param-
eters during treatment delivery, i.e. gantry rotation speed,
treatment aperture shape via movement  of MLC leaves and
dose rate. VMAT  is a time efﬁcient treatment delivery plat-
form capable of producing highly conformal dose distributions
with a single 360◦ arc.1 There is a signiﬁcant increase in
delivery of stereotactic body radiotherapy (SBRT), a kind of
ablative treatment, with volumetric modulated arc delivery,
because of better reduction of doses to surrounding critical
organs and normal structures with a short delivery time.2
SBRT has emerged as an alternative treatment option to sur-
gical resection for patients who  are medically inoperable;
giving excellent local control rates (up to 95%).3 Delivering
SBRT with the technique of intensity modulation can improve
dose conformity compared with conventional radiotherapy4
by creating many  beamlets that are differently weighted in
the treatment planning optimizing software. Several plan-
ning studies have evaluated the performance of VMAT in
delivering SBRT.5–8 Generally, VMAT  planning has a two-stage
optimization in which ﬂuence-map-based optimization algo-
rithm calculates optimized ﬂuence maps as a series of discrete
beam angles and subsequently, an arc sequencer algorithm
converts the ﬂuence maps for multiple ﬁxed-angle delivery
to those for arc delivery while optimizing an MLC leaf shape
sequence.9 VMAT  uses sweeping leaf sequencer to create an
arc treatment plan using an MLC  to shape a radiation ﬁeld
so that the delivered dose volume conforms well to a given
prescribed dose volume.
SBRT delivers a very high dose per fraction of radiation for
ﬁve or fewer fractions. Most tumors planned for SBRT are early
in stage, more  localized, regular and smaller in dimension.
Moreover, it has the major challenges in patient immobiliza-
tion, contouring, and respiratory organ motion management
and delivery accuracy. For SBRT, a crucial patient speciﬁc plan-
ning target volume is required to improve a targeting and
delivery accuracy as well as to potentially reduce the dose
to surrounding normal tissues and critical organs. Besides,
organ motion has become an important consideration for
SBRT treatment planning for tumors in the thorax, abdomen
and prostate that are known to move with breathing motion.10
The management of motion control is established with the
setup of motion encompassing methods such as respira-
tory gated imaging, breath hold technique, forced shallow
breathing with abdominal compression, etc. Also, a stringent
tolerance limit is required in MLC  leaf position to deliver the
dose in small and highly complex apertures created by the
VMAT optimization. However, the redundancy of modulation
for regularly shaped small volume tumors creates a large
number of smaller segments with a consequent increase in
monitor units, treatment time and dosimetric uncertainties.
The dose calculation algorithm has a difﬁculty in predicting
the dose accurately for these segments because of the lack of
charged particle equilibrium and requires precise modelling
of lateral electron scatter.11 Unlike conventional radiotherapy,iotherapy 1 9 ( 2 0 1 4 ) 287–295
any small uncertainty in the dose calculation for the small,
narrow and irregular segments will have a notable impact on
the accuracy of delivering the requisite high dose per frac-
tion. Young et al. have discussed the use of edge penalty
during optimization that reduces the required MUs  up to 30%
by avoiding the creation of complex apertures and increases
accuracy of dose delivery with gamma passing rate from 79.5%
to about 95.4%.12 Hence the creation of such smaller segments
can be controlled with sequencing parameters by the segmen-
tation of theoretical ﬂuence into deliverable MLC  segments.
The minimum segment width parameter in the segmentation
process has a signiﬁcant role in the creation of segments with
different sizes and shapes. This study investigates the plan
delivery and quality with different penalty on segment width
in volumetric modulated arc (VMAT) delivery for SBRT cases.
2.  Methods  and  materials
2.1.  Patient  selection  and  simulation
A total of 18 patients treated for SBRT were taken for this
study. This included six cases each of lung, abdomen and liver
sites. For the lung, stage I/II non-small-cell lung cancer and
for the liver, hepatocellular carcinoma and metastatic tumors
were taken, while abdominal cases studied were pancreas,
lymph nodes and adrenal gland tumors. The average PTV vol-
ume  for lung, liver and abdomen cases were 38.8 cm3 (range
18.6–58.6 cm3), 120.1 cm3 (range 30.9–280.3 cm3) and 154.6 cm3
(range 30.9–280.3 cm3), respectively. All these patients were
simulated with the vac-lac immobilization system with hands
above the head position for both simulation and treatment
procedure. For all the patients, simulation study were done
with computed tomography imaging on 64 slice Biograph mCT
15 cms  above and below the upper and lower limit of the target
to encompass all organs at risk and obtain geometric and dosi-
metric information for the treatment setup. The patients were
scanned in a continuous mode with gantry rotation time of
0.5 s and reconstructed in 2 mm slice thickness for precise tar-
get delineation. Since tumors of the lung, liver, and abdomen
are prone to move with respiratory motion, Active Breath-
ing Coordinator system was applied for patients undergoing
treatment for lung and liver cancers to manage the respira-
tory motion. For patients with other intra-abdominal tumors,
a stringent immobilization was done using BodyFix system
from Elekta.
2.2.  Contouring  and  dose  prescription
Based on multimodality imaging process, gross tumor volume
(GTV) for all the sites were deﬁned on primary CT image  by an
experienced radiation oncologist and checked with radiologist
as per the multidisciplinary protocol of the institution. Using
CMS FocalSim 4.6v (Elekta, Maryland Heights, MO, USA) virtual
simulation workstation patient-speciﬁc margins were applied
for the GTV to the planning target volume (PTV) expansion
with superior/inferior marginal range of 7–10 mm and axial
margin of 5–7 mm.  In addition, organs at risk (OARs), such
as the lung, liver, spinal cord, heart, kidneys and, if relevant,
bowel, esophagus were delineated corresponding to the tumor
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Table 1 – Metrics of DVH showing difference in Target Coverage (PTV D95) for different Minimum Segment Width (MSW) while maintaining the similarity on critical
organ doses as the mean ± SD for three different MSW  plans.
(a) Lung cases
Tumor
vol (cc)
Rx Gy × Fr PTV D95 (Gy) Mean + SD for 3 different MSW  plans
0.5 cm 1.0 cm 1.5 cm IpLung-PTV (cc) ConLung D20 (Gy) Heart D20 (Gy) Ribs Max  (Gy) Spine Max
(Gy)
Pt 1 52.8 15 × 4 60.8 60.5 59.5 332 ± 6 (V20)  648 ± 9 (V10)  2.8 ± 0.8 9.6 ± 0.8 57.5 ± 0.05 12.0 ± 0.3
Pt 2 24.8 15 × 4 60.2 60.3 59.4 156 ± 2 (V20)  219 ± 5 (V10)  1.8 ± 0.09 NCR 66.5 ± 0.09 13.8 ± 0.3
Pt 3 33.2 15 × 3 44.7 45.1 44.1 123 ± 5 (V20)  283 ± 7 (V10)  2.4 ± 0.3 NCR 46.3 ± 0.4 17.8 ± 0.3
Pt 4 18.6 15 × 3 59.5 59.3 58.3 192 ± 6 (V20)  308 ± 5 (V10)  8.2 ± 0.5 3.6 ± 0.2 NCR 21.4 ± 0.5
Pt 5 31.8 20 × 3 60.6 60.2 59.2 188 ± 4 (V20)501 ± 12 (V10) 2.5 ± 0.06 7.0 ± 0.2 52.5 ± 0.4 5.6 ± 0.2
Pt 6 32.6 15 × 3 44.8 44.5 44.1 163 ± 8 (V20)535 ± 18 (V10) 2.7 ± 0.2 NCR 48.4 ± 0.5 6.9 ± 0.1
(b) Liver cases
Tumor
vol (cc)
Rx Gy × Fr PTV D95 (Gy) Mean + SD for 3 different MSW  plans
0.5 cm 1.0 cm 1.5 cm Liver (cc) Rt Kidney D20 (Gy) Lt Kidney D20 (Gy) Bowel Max  (Gy) Spine Max
(Gy)
Pt 7 241.8 8 × 5 38.5 37.7 36.9 371 ± 7 (V20)687 ± 11 (V10) 24.2 ± 0.1 6.3 ± 0.02 36.9 ± 0.3 25.6 ± 0.1
Pt 8 30.1 15 × 4 61.7 61.7 61.0 170 ± 3 (V20) 433 ± 9 (V10) NCR NCR NCR NCR
Pt 9 18.4 8 × 5 39.9 39.8 38.3 54 ± 3 (V20) 174 ± 7 (V10) NCR NCR NCR NCR
Pt 10 101.9 15 × 3 42.2 42.6 41.3 297 ± 6 (V20)822 ± 11 (V10) NCR NCR 23.7 ± 0.3 NCR
Pt 11 61.3 15 × 4 61.0 60.6 59.6 396 ± 8 (V20)746 ± 12 (V10) 3.8 ± 0.3 2.5 ± 0.1 NCR 16.8 ± 0.2
Pt 12 146.8 8 × 5 40.5 40.9 39.8 144 ± 3 (V20) 372 ± 6 (V10) 4.4 ± 0.2 NCR 22.1 ± 0.5 8.6 ± 0.2
(c) Abdomen cases
Tumor
vol (cc)
Rx Gy × Fr PTV D95(Gy) Mean + SD for 3different MSW  plans
0.5 cm 1.0 cm 1.5 cm Rt Kidney D20 (Gy) Lt Kidney D20 (Gy) Liver D20 (Gy) Bowel Max (Gy) Stomach Max  (Gy) Esophagus
Max  (Gy)
Pt 13 115.2 20 × 3 37.1 36.6 36.0 7.4 ± 0.6 18.5 1.3 ± 0.03 24.9 ± 0.3 NCR NCR
Pt 14 171.3 12 × 4 48.8 49.2 48.1 7.2 ± 0.04 NCR NCR 41.4 ± 0.2 NCR NCR
Pt 15 30.9 12 × 3 33.9 34.0 32.8 18.3 ± 0.3 17.6 ± 0.3 9.7 ± 0.3 36.2 ± 0.6 NCR NCR
Pt 16 280.3 7 × 5 35.4 35.4 34.1 4.3 ± 0.5 3.3 ± 0.4 11.0 ± 0.09 NCR 20.4 ± 0.2 NCR
Pt 17 60.8 7 × 5 59.3 59.7 59.5 8.9 ± 0.4 8.2 ± 0.5 18.5 ± 0.05 NCR 52.2 ± 0.1 34.8 ± 0.1
Pt 18 114.4 7 × 5 34.2 34.1 32.6 7.1 ± 0.1 6.9 ± 0.2 8.0 ± 0.08 – – –
NCR, Not Clinically Relevant.
d rad290  reports of practical oncology an
location. Each patient for lung, liver and abdomen cancer were
planned on the RTOG 0915 protocol that delivers the prescrip-
tion dose in the range of 7 Gy/fx to 20 Gy/fx. The stated goals for
the tumors were to deliver 90–99% of prescription dose to cover
95% of its volume while allowing the maximum doses into GTV
by up to 120–140% of prescription dose. For critical structures,
the maximum dose for serial organs and volume constrains
for parallel structures were respected based on total dose and
dose per fraction using departmental protocol. The total num-
ber of fractions ranged from 1 to 5 and it is shown in Table 1.
2.3.  Treatment  planning
2.3.1.  General  parameters
For all patients, VMAT SBRT plans were developed using CMS
Monaco 3.1 (Elekta, Maryland Heights, Missouri, USA) treat-
ment planning system and the plans were delivered using
Elekta Synergy® (Elekta, Crawley, UK) machine equipped with
a Beam Modulator head assembly consisting of 40 paired
leaves, each measuring 4 mm in width at the isocenter and
Cone-Beam Computed Tomography (CBCT) device (XVI®) for
volumetric imaging. The treatment planning in Monaco TPS is
a two step process where theoretical ﬂuence is created based
on given dose constraints and followed by segmentation of
theoretical ﬂuence into deliverable MLC  segments. Each case
was planned with a single arc either complete or a partial
coplanar arc depending upon the location of tumor to avoid
the dose to the contralateral organs. The gantry of an acceler-
ator cannot pass from 180◦ to −180◦ and vice versa, hence the
ideal partial arcs often have to be delivered by splitting into
two partial arcs. Thus, the two partial arcs were disjointed
and delivered as part of the same gantry rotation. The arc
length was in the range of 200–360◦ with an increment of
10–20◦ and ﬂuence smoothing parameters at medium mode.
The number of control points per arc was kept in the range of
180–300, depending on the length of arc. Monte Carlo was cho-
sen as a secondary algorithm for segmentation and ﬁnal dose
was calculated with a calculation grid resolution of 2.5 mm.
The physical parameters, like number of arcs, arc length,
increment, number of control points/arc, ﬂuence smoothing
parameters were all kept the same for all three different plans
with different minimum segment width in each case. Homo-
geneity correction was used in all the plans.
2.3.2.  Minimum  segment  width
During plan optimization, sequencing algorithm may create
a higher number of monitor units and segments to generate
intensity maps by creation of small and narrow segments. In
Monaco VMAT,  sequencing is based on an alternative Sliding
Window pattern in which all the leaves move from start to
end position in a continuous, unidirectional manner. The leaf
assembly moves ﬁrst one way and then the other way alternat-
ing between sectors of the full arc and varying the leaf speeds
and the gaps are produced between opposing leaves, while
the system modulates intensity of the delivered ﬂuence. The
parameter minimum segment width (MSW)  was used in the
sequencing algorithm to determine the minimum leaf sep-
aration between two opposing leaves within the segmented
ﬁeld of any given segment. Thus, the parameter MSW was
devised to generate a sequence with limited narrow segmentsiotherapy 1 9 ( 2 0 1 4 ) 287–295
for plan delivery. The range of values allowable in the opti-
mizer is 0.5–2.0 cm.  Three VMAT SBRT plans were generated
with different penalties on MSW of 0.5, 1.0 and 1.5 cm for each
case in the study.
2.4.  Plan  evaluation
For lung cases, the OARs were the healthy ipsilateral lung, con-
tralateral lung, heart and spinal cord. The OARs for the liver
and abdomen cases were the healthy liver, kidneys, bowel,
spinal cord, esophagus and stomach subject to involvement
in the beam path. The qualitative analysis for the differently
penalized plans were performed based on the comparison of
dosimetric indices (DIs) such as
(i) Target coverage (TC), which is deﬁned as the ratio of total
target volume receiving at least the prescription dose to the
total target volume;
TC = TVPI/TV, where TV is the target volume;
(ii) Conformity index (CI), which is the ratio of the total vol-
ume  receiving the prescription dose VPI to the target volume
receiving at least the prescription TVPI;
CI = VPI/TVPI
(iii) Conformity number (CN) which is the ratio of the target
coverage to CI; and
CN = TC/CI or (TVPI)2/(TV × VPI),
(iv) Gradient index (GI) which is the ratio of the volume of
50% of the prescription isodose to the volume of the prescrip-
tion isodose;
GI = V50PI/VPI, where V50PI is the volume of 50% of the pre-
scription isodose.
The monitor units (MUs) and delivery accuracy were ana-
lyzed for all differently penalized plans.
2.5.  Delivery  analysis
The accuracy of the dose calculation algorithm on all VMAT
SBRT plans with different penalties of MSW  was evaluated
from the measured ﬂuence by a Matrixx 2D detector ion cham-
ber for all arc segments with the beam central axis oriented
perpendicular to the plane of the detector. In order to do the
measured versus calculated dose analysis, the treatment plan-
ning system was used to calculate a separate dose distribution
to a ﬂat solid-water phantom for the VMAT SBRT arcs and dose
planes of individual arcs at a speciﬁed SSD and depth in phan-
tom. In this study, the dose was calculated for a plane at 11 cm
depth, which corresponds to the plane of ionchambers of the
Matrixx with 11 cm build-up, and SSD of 89 cm.  The effect of
the MSWs  on delivery accuracy was quantitatively analyzed
using Omnipro IMRT software. The measured and computed
doses were analyzed by both point dose veriﬁcation and pla-
nar dose measurements with gamma  analysis using a 2% of
dose difference and 2 mm of distance to agreement criteria.
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or collaboration, three more  cases were measured for dose
alculation veriﬁcation using a small PMMA phantom with
16 in perceptiveness of matrix measurement as point dose
eriﬁcation with computed dose.
.  Results
o have an accurate comparison, each plan with different
enalties of MSW  was made in a way to achieve the same
ose distribution and effect on dosimetric indices, plan efﬁ-
iency in terms of MUs  and delivery accuracy was analyzed.
or doing so, the plans with 0.5 cm of MSW  (MSW) were taken
s reference and compared with other two plans. Fig. 1 shows
he difference in total MUs  for different segments width opti-
ization schemes. For all the cases, plan with 0.5 cm of MSW
howed a higher value of total MUs. When compared with the
eference plan, the mean reduction of total MUs for the plan
ith 1.0 cm and 1.5 cm of MSW  was observed as 12.7 ± 6.0%
nd 17.5 ± 7.2%, respectively. The maximum variation of 23.2%
nd 32.5% of decrease in total MUs  was observed for plans
ith 1.0 cm and 1.5 cm of MSW,  respectively. In all the ﬁgures,
Table 2 – Deviation of dosimetric indices for plans with 1.0 cm a
signiﬁcance were  calculated using Student’s t-test.
MSW  1.0 cm 
Mean Diff. Std. Dev. p-Value 
TC 0.00 0.0091 0.984†
CI −0.02 0.0454 0.1318†
CN 0.01 0.0308 0.1504†
GI 0.04 0.2301 0.420†
† Not signiﬁcant.
∗ Highly signiﬁcant.m,  1.0 cm and 1.5 cm of minimum segment width.
patient Pt1–Pt6, Pt7–Pt12, and Pt13–Pt18 represented lung, liver
and abdomen cases, respectively.
The metrics of DVHs planned for different penalties of
MSW are shown in Table 1. For the lung cases, the percentage
of normal ipsilateral lung volume exceeding 20 Gy (V20), 10 Gy
(V10) and dose to 20% of contra lateral lung were compared.
For liver and abdominal tumors, the percentage of normal liver
volume exceeding 20 Gy (V20), 10 Gy (V10) and dose to 20% (D20)
of kidneys were taken for the assessment. The dose maximum
(0.01%) to the bowel, spine, stomach, esophagus and organs
receiving relatively low dose were also analyzed as shown in
Table 1. For most of the patients, metrics of critical organs from
DVH for differently optimized plans were well within ±3%.  For
a few cases, the OAR dose values had a deviation outside 3%
that was not clinically signiﬁcant. For all the treatment plans,
90–99% of prescription dose covered 95% of tumor volume.
Fig. 2 shows the deviation in target coverage (TC), conformity
index (CI), conformity number (CN) and gradient index (GI) for
three different optimization scenarios. Table 2 lists the statis-
tical data of paired two tailed t-tests which demonstrates the
signiﬁcance of TC, CI, CN and GI for the plans with 1.0 cm and
1.5 cm of MSW. The p-value (p > 0.05) of mean and standard
deviation for TC, CI, CN and GI demonstrated no signiﬁcance
nd 1.5 cm of MSW w.r.t. plan with 0.5 cm of MSW.  The
MSW 1.5 cm
Mean Diff. Std. Dev. p-Value
0.03 0.0167 <0.0001*
−0.06 0.0669 0.0005*
0.06 0.0440 <0.0001*
−0.02 0.2648 0.7572†
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Fig. 2 – Comparison of normalized dosimetric indices like target coverage (TC), conformity index (CI), conformity number
(CN) and gradient index (GI) for plans with different minimum segment width.for plans with 1.0 cm of MSW  when compared with the 0.5 cm
MSW  plans. The t-test demonstrated a signiﬁcant difference
(p < 0.001) in TC, CI and CN for the plans with 1.5 cm of MSW
when compared with the reference plan.All treatment plan dosimetric endpoints are shown in
Fig. 1. Measured point doses for all the plans with 0.5 cm
of MSW had a slightly higher deviation from TPS computed
dose of average percentage deviation of 2.96 ± 1.07% and the
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Fig. 3 – QA results of point dose deviation in CAX and ﬂuence passing rate between TPS calculated and measured data using
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datrix 2D ion chamber array for all eighteen patients in thre
ighest percentage difference for plan with 0.5 cm of MSW
as 4.5%. Maximum number of plans with 1.0 cm and 1.5 cm
f MSW  had a deviation of <3%. The mean and standard devia-
ion of point dose variation between computed and measured
ose were 3.0 ± 1.1%, 2.1 ± 0.84% and 1.8 ± 0.9% for the plans
ith 0.5 cm,  1.0 cm and 1.5 cm of MSW,  respectively. Table 2
hows the mean and standard error of the percent difference
n each point dose and planar dose measurement for all
MAT  SBRT plans. The direction of the point dose deviation
easured by MatriXX for different scenarios of VMAT  SBRT
lans was veriﬁed for three patients by A16 microchamber
oint dose measurement. Similar to 2D array results, point
ose measurement using A16 ion chamber showed a higher
eviation for 0.5 cm of MSW  plans when compared to other
Table 3 – Validation/justiﬁcation of SBRT QA results of
matrix 2D ion chamber array measurement with A16
micro-ion chamber results. The Mean ± SD of percentage
deviation of TPS calculated and measured CAX dose for
three patients i.e. nine plans.
MSW  0.5 cm MSW  1.0 cm MSW 1.5 cm
Matrix 2.96 ± 1.07 2.09 ± 0.85 1.76 ± 0.91
A16 2.57 ± 0.76 1.37 ± 0.67 0.93 ± 0.64
All dosimetric data were expressed in percentage.ferent i.e. 0.5, 1.0, 1.5 cm of minimum segment width plans.
two scenarios as shown in Table 3. Comparison of measured
planar dose and TPS calculated dose plan was analyzed with
passing criteria of 2% dose difference and 2 mm of distance to
agreement. The mean and standard deviation of the passing
rate was 95.9 ± 1.1%, 97.2 ± 1.4% and 98.1 ± 1.0% for the plans
with 0.5 cm,  1.0 cm and 1.5 cm of MSW, respectively (Fig. 3).
4.  Discussion
The study compares three different VMAT  SBRT optimization
schemes with difference in MSW. We  compared the plan qual-
ity both by analysing the dose volume histogram and delivery
efﬁciency in terms of total plan MUs and deviation from
measured dose to TPS calculated dose. Most of the tumors
undergoing SBRT are smaller and regular in dimension and
require a very high dose per fraction. The proximity of criti-
cal organs and tumor necessitates beam intensity modulation
with inverse planning. The plan optimization for all these
tumors increased the complexity by forming a large number
of smaller and irregular optimized apertures. We  investigated
the increase in complexity of apertures and its consequent
increased monitor units with resultant uncertainties in deliv-
ery due to the nature of small ﬁelds. The analysis of the
VMAT SBRT plans with a different penalty on minimum seg-
ment width during segment shape optimization illustrated
a signiﬁcant difference in TPS calculated monitor units and
d rad
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some deviations in measured and TPS calculated dose distri-
bution. The results were 23.2% variation for 1 cm and 32.5%
for 1.5 cm of minimum segment width (MSW)  with resultant
reduction of the number of total monitor units. The decrease
in MUs  was seen with increasing minimum segment width
values to 1.0 cm and 1.5 cm during segment shape optimiza-
tion. Metrics obtained from the dose volume histogram of
differently penalized plans showed similarity in dose distribu-
tion with insigniﬁcant variation of dose to organs at risk and
minimal impact on target coverage. VMAT  SBRT plans with
0.5 cm of MSW  demonstrated a better dosimetric index with a
resultant increase in monitor units and a higher deviation with
TPS calculated to measured point dose and ﬂuence passing
rate. On the other hand, the plan with 1.5 cm of minimum seg-
ment width resulted in a better agreement with TPS calculated
for both point dose and ﬂuence veriﬁcation on delivery with
reduced MUs  with a degradation in plan quality. At the same
time, VMAT  SBRT plan generated with 1.0 cm of minimum
segment width had a similar dose distribution as plans with
0.5 cm of minimum width, in addition to better plan efﬁciency
of increased delivery accuracy and reduced monitor units.
In a study by Young et al., the reduction in the number of
monitor units through aperture regularization minimized the
required leaf motion during dynamic delivery thereby poten-
tially reduced the delivery time.17 The use of segment width
restrictions, such as increasing the minimum segment width
to an extent during optimization, introduces the possibil-
ity of reducing redundant modulation and increases delivery
efﬁciency as long as the limits are not so strict as to inter-
fere with the dosimetric plan objectives. Generally, in IMRT
treatment planning, intensity distributions created by opti-
mization systems are converted into trajectories of leaves to
deliver desired dose distributions to produce two-dimensional
non-uniform proﬁles of arbitrary shape. The beamlet intensity
restrictions, smoothing procedures, direct aperture optimiza-
tion, etc., were proposed by many  authors for reducing the
beam complexity on treatment planning and delivery for
complex intensity patterns while maintaining the dosimetric
quality.18–24 The change in the inherent segment sequencing
parameter of minimum segment width has the positive effect
of reducing the MUs  needed for delivering very high dose of
uncomplicated intensity patterns. Also, a large decrease in
plan modulation not only improves delivery efﬁciency, but also
potentially decreases planning and quality assurance time or
difﬁculty.12–15
The patients undergoing hypofractionated treatment for
tumors of the thorax and abdomen are more  prone to have
respiratory motion. These respiratory motions in the SBRT
cases are manageable with the systems like Active Breath-
ing Coordinator, respiratory gating, forced shallow breathing,
etc., as per patient’s comfort. Decreasing of MU for treatment
delivery will reduce the treatment time and increase the com-
fort for patients, especially for patients undergoing treatment
with motion management systems. Many  of the VMAT SBRT
plans for this study were delivered with the breathhold tech-
nique, so an exact determination of the reduction in treatment
time is not possible because of the change in patient’s capabil-
ity in the breathhold position. Furthermore, it is well known
that the main part of out-of-ﬁeld doses are due to the linac-
head scatter and leakage radiation are proportional to totaliotherapy 1 9 ( 2 0 1 4 ) 287–295
MUs delivered.16,17 Hypothesis of increasing risk of secondary
malignancies would be a sufﬁcient justiﬁcation to attempt a
reduction in the MUs delivered to patients while maintaining
a high dose to the target volumes and low dose to critical organ
and surrounding normal tissues.
The QA results of each plan with different penalties on
segment width were measured and it was shown that for
patients calculated with higher penalty on minimum seg-
ment width there was a better agreement with the calculated
dose from TPS. The mean and standard deviation of percent-
age difference between calculated and measured point dose
showed an increased accuracy for the higher value of mini-
mum segment width. Furthermore, the results of the ﬂuence
veriﬁcation with 2%/2 mm of passing criteria of gamma had
an increased passing rate for the plan with less complexity
on apertures. However, the plan quality was degraded with
increased MSW. For many  cases, signiﬁcant change in the tar-
get coverage was observed for 1.5 cm of MSW  plans. Increasing
the value of minimum segment width to an optimal value
during plan optimization can help to prevent the creation of
very small and complex segments for tumors with regular
dimensions, especially for targets taken for the hypofraction-
ation. Meanwhile with attempt of increasing the minimum
segment width during plan optimization for irregular and con-
cave shaped tumors, signiﬁcant variation in target coverage
and dose distribution was observed.
5.  Conclusion
We planned stereotactic body radiotherapy with volumetric
modulated arc for extracranial lesions with three different
scenarios creating a change in minimum segment width dur-
ing plan optimization. Different penalties were investigated
for range of tumors of the lung, liver and abdomen. In an
overall view among the calculated MUs, delivery accuracy
and plan quality, the plans with optimally increased value
of 1 cm of minimum segment width show a clear merit in
trade off between better plan quality and delivery efﬁciency for
stereotactic body radiotherapy. Reducing MUs  by controlling
redundant modulation for VMAT SBRT plans with optimal val-
ues of minimum segment width will also increase the comfort
for patients undergoing treatment with motion management
system.
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